Citi Pharma posts flat 9MFY25 profit at nearly Rs680m

News Image

By MG News | April 30, 2025 at 04:46 PM GMT+05:00

0:00

April 30, 2025 (MLN): Citi Pharma Ltd. (PSX: CPHL) reported a net profit of Rs678.84 million for the nine months ended March 31, 2025, nearly unchanged from Rs681.40m in SPLY, reflecting a flat performance despite a decline in pre-tax earnings.

Earnings per share stood at Rs2.97, slightly down from Rs2.98 a year ago.

The company’s net sales rose 6% to Rs10.10 billion from Rs9.54bn, driven by increased demand and operational scale.

Cost of sales grew proportionately by 6% to Rs8.64bn, keeping gross profit growth at 8%, amounting to Rs1.46bn.

However, operating profit also rose 8% to Rs1.17bn despite higher selling expenses, which surged 19% to Rs119.70m.

Citi Pharma’s financial cost increased 15% to Rs231.51m, while other income sharply declined by 47% to Rs165.82m, reducing support to the bottom line. As a result, profit before income taxes and final tax fell by 8% to Rs1.03bn.

Taxation decreased by 20% year-on-year to Rs349.84m, helping offset some of the pressure on net profit.

Condensed interim statement of profit and loss for the nine month ended 31 March 2025 (in Rupees) 2025 2024 %Change
Sales - Net           10,100,185,059             9,535,266,706 6%
Cost of Sales            (8,643,865,934)            (8,192,103,683) 6%
Gross Profit             1,456,319,125             1,343,163,023 8%
Administrative Expenses                161,904,092                154,757,727 5%
Selling Expenses                119,703,970                100,497,146 19%
Operating Profit             1,174,711,063             1,087,908,150 8%
Financial (Cost) / Income               (231,505,104)               (200,800,962) 15%
Other Income/(Loss)                165,818,206                312,952,864 -47%
Other Expenses                 (80,335,099)                 (82,062,737) -2%
Profit before income taxes and final tax             1,028,689,066             1,117,997,315 -8%
Taxation - Final taxes                           (4,004)                       (255,970) -98%
Profit before income tax             1,028,685,062             1,117,741,345 -8%
Taxation - Income tax               (349,842,286)               (436,344,074) -20%
Profit after income tax                678,842,776                681,397,271 0%
Earnings per share (EPS) - Basic and Diluted 2.97 2.98  

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 133,403.19
324.46M
0.02%
33.04
ALLSHR 83,188.05
1,204.34M
0.13%
106.90
KSE30 40,651.46
104.88M
-0.13%
-53.85
KMI30 192,083.92
123.92M
-0.26%
-496.76
KMIALLSHR 55,847.70
679.22M
0.02%
11.98
BKTi 36,422.88
17.65M
0.29%
105.71
OGTi 28,437.61
10.77M
-0.37%
-105.35
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 109,060.00 109,685.00
107,680.00
605.00
0.56%
BRENT CRUDE 69.80 69.83
69.03
0.22
0.32%
RICHARDS BAY COAL MONTHLY 97.50 0.00
0.00
2.05
2.15%
ROTTERDAM COAL MONTHLY 106.65 106.65
106.25
0.50
0.47%
USD RBD PALM OLEIN 998.50 998.50
998.50
0.00
0.00%
CRUDE OIL - WTI 68.05 68.07
67.33
0.12
0.18%
SUGAR #11 WORLD 16.22 16.37
16.13
-0.06
-0.37%

Chart of the Day


Latest News
July 08, 2025 at 05:29 PM GMT+05:00

Money Link Exchange shuts down operations


July 08, 2025 at 04:41 PM GMT+05:00

Gold price in Pakistan rises Rs1,500 per tola


July 08, 2025 at 04:25 PM GMT+05:00

CCP clears 69 M&A deals in FY25


July 08, 2025 at 04:00 PM GMT+05:00

PSX Closing Bell: Holding the Line



Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg